India, May 7, 2025:  Venus Remedies Limited (NSE: VENUSREM, BSE: 526953), a leading global pharmaceutical company, has appointed Ms. Ekta S. Chaudhary as the Chairperson of Venus Foundation, the dedicated social impact arm of the organization. 

In this leadership role, Ms. Chaudhary will drive the company’s corporate social responsibility (CSR) agenda, focusing on healthcare access, educational advancement, and inclusive community development. Her appointment marks a significant step in strengthening the Foundation’s impact-driven initiatives aligned with Venus Remedies’ core values of equity, empowerment and environmental stewardship. 

“We are delighted to welcome Ms. Ekta as Chairperson of Venus Foundation. Her vision, dedication, and global perspective make her uniquely positioned to lead our mission of creating meaningful and sustainable social change. I am confident her leadership will accelerate our efforts in areas such as women’s empowerment and healthcare equity,” said Mr. Pawan Chaudhary, Chairman and Managing Director, Venus Remedies Ltd. 

The appointment reflects Venus Remedies’ commitment to evolving its CSR framework under future-ready leadership that blends scientific understanding with a passion for community welfare. 

“Joining Venus Foundation is a unique opportunity to work alongside a purpose-driven team committed to operational excellence and social progress. I look forward to advancing the company’s CSR footprint by fostering a culture of inclusive growth. Together, we aim to build enduring partnerships and programs that empower individuals to lead change in their communities,” said Ms. Ekta S. Chaudhary, Chairperson, Venus Foundation. 

A microbiologist by qualification, Ms. Chaudhary holds a degree from the University of Nottingham, a leading Russell Group institution in the UK. A passionate advocate for environmental action, she played a key role in launching Earthfest—London’s first large-scale sustainability festival—bringing together change makers, innovators, and thought leaders to raise awareness about climate action and responsible living. With early experience in the biotech and AI space in London, she is now channeling her global exposure and scientific perspective into purpose-driven work, marking the beginning of her journey in corporate social responsibility and community impact. 

Since its inception, Venus Remedies has remained steadfast in its commitment to making a meaningful difference in the society through its initiatives. The company views education as a fundamental pillar of societal progress and has made consistent investments in the upliftment and modernization of government schools in Panchkula, creating more conducive and empowering learning environments for students. With the formal establishment of the Venus Foundation, the company seeks to further institutionalize its CSR outreach and deepen community partnerships, enabling lasting and scalable impact across key development areas. 

About Venus Remedies  

Panchkula-based Venus Remedies Ltd (NSE: VENUSREM, BSE: 526953) is among the 10 leading fixed-dosage injectable manufacturers in the world. Having a commercial presence in 80+ countries with a portfolio of 75 products spread over Europe, Australia, Africa, Asia-Pacific, Commonwealth States, the Middle East, Latin America and the Caribbean region, the company has nine globally benchmarked facilities in Panchkula, Baddi and Werne (Germany), apart from 11 overseas marketing offices. Its manufacturing units are certified for ISO 9001, ISO 14001, ISO 18001 and OHSAS. The company has also been approved by European- GMP, WHO-GMP and Latin American GMP (INVIMA), among others. Ranked 107th in Asia and among the world’s 500 largest pharmaceutical manufacturing companies, Venus Remedies has been granted more than 130 patents worldwide and having more than 75 registered trademarks and more than 15 copyrights for its innovative research products. Moreover, in 2025, Venus Remedies received recognition as a ‘Great Place to Work’ for the fourth consecutive time.